Previous Section
Clinical Trials
1. A phase II study of VEPA/FEPP chemotherapy for aggressive lymphoma in elderly patients: Japan Clinical Oncology Group Study JCOG9203.
- Author
- Mizoroki F; Hirose Y; Sano M; Fukuda H; Tobinai K; Nakata M; Taniwaki M; Kawano F; Uozumi K; Sawada K; Fukuhara S; Nasu K; Ohno Y; Toki H; Togawa A; Kikuchi M; Hotta T; Shimoyama M;
- Institution
- Division of Hematology and Oncology, Daisan Hospital, Jikei University School of Medicine, Komaeshi, Tokyo 201-8601, Japan. fumi@jikei.ac.jp
- Journal
- Int J Hematol. 2006 Jan;83(1):55-62.
- Abstract URL
- Click here to view abstract
2. Frontline therapy with early intensification and autologous stem cell transplantation versus conventional chemotherapy in unselected high-risk, aggressive non-Hodgkin's lymphoma patients: a prospective randomized GEMOH report.
- Author
- Baldissera RC; Nucci M; Vigorito AC; Maiolino A; Simoes BP; Lorand-Metze I; Aranha FJ; Miranda EC; Pagnano KB; Ruiz MA; Moraes AA; De Souza CA;
- Institution
- Marilia Medical School, Sao Paulo, Brazil.
- Journal
- Acta Haematol. 2006;115(1-2):15-21.
- Abstract URL
- Click here to view abstract
3. Autologous stem cell transplantation in elderly (>60 years) patients with non-Hodgkin's lymphoma: a nation-wide analysis.
- Author
- Jantunen E; Itala M; Juvonen E; Leppa S; Keskinen L; Vasala K; Remes K; Wiklund T; Elonen E; Nousiainen T;
- Institution
- Department of Medicine, Kuopio University Hospital, Kuopio, Finland. esa.jantunen@kuh.fi
- Journal
- Bone Marrow Transplant. 2006 Feb;37(4):367-72.
- Abstract URL
- Click here to view abstract
4. Vinorelbine, gemcitabine, procarbazine and prednisone (ViGePP) as salvage therapy in relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL): results of a phase II study conducted by the Gruppo Italiano per lo Studio dei Linfomi.
- Author
- Di Renzo N; Brugiatelli M; Montanini A; Vigliotti ML; Cervetti G; Liberati AM; Luminari S; Spedini P; Giglio G; Federico M;
- Institution
- Unita Operativa di Ematologia ed Oncologia Medica, C.R.O.B., Ospedale Oncologico Regionale, Rionero in Vulture, (PZ), Italy. ndirenzo@crob.it
- Journal
- Leuk Lymphoma. 2006 Mar;47(3):473-9.
- Abstract URL
- Click here to view abstract
5. Phase III intergroup study of fludarabine phosphate compared with cyclophosphamide, vincristine, and prednisone chemotherapy in newly diagnosed patients with stage III and IV low-grade malignant Non-Hodgkin's lymphoma.
- Author
- Hagenbeek A; Eghbali H; Monfardini S; Vitolo U; Hoskin PJ; de Wolf-Peeters C; MacLennan K; Staab-Renner E; Kalmus J; Schott A; Teodorovic I; Negrouk A; van Glabbeke M; Marcus R; Hagenbeek A; Eghbali H; Monfardini S; Vitolo U; Hoskin PJ; de Wolf-Peeters C; MacLennan K; Staab-Renner E; Kalmus J; Schott A; Teodorovic I; Negrouk A; van Glabbeke M; Marcus R;
- Institution
- European Organisation for Research and Treatment of Cancer (EORTC) Lymphoma Group, Amsterdam, The Netherlands. a.hagenbeek@amc.uva.nl
- Journal
- J Clin Oncol. 2006 Apr 1;24(10):1590-6.
- Abstract URL
- Click here to view abstract
6. A phase III trial comparing CHOP to PMitCEBO with or without G-CSF in patients aged 60 plus with aggressive non-Hodgkin's lymphoma.
- Author
- Burton C; Linch D; Hoskin P; Milligan D; Dyer MJ; Hancock B; Mouncey P; Smith P; Qian W; MacLennan K; Jack A; Webb A; Cunningham D; Burton C; Linch D; Hoskin P; Milligan D; Dyer MJ; Hancock B; Mouncey P; Smith P; Qian W; MacLennan K; Jack A; Webb A; Cunningham D;
- Institution
- University College London and CRUK Clinical Trials Centre, 222 Euston Road, London NW1 2DA, UK.
- Journal
- Br J Cancer. 2006 Mar 27;94(6):806-13.
- Abstract URL
- Click here to view abstract
7. Acquired immunodeficiency syndrome-related lymphoma: simultaneous treatment with combined cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy and highly active antiretroviral therapy is safe and improves survival--results of the German Multicenter Trial.
- Author
- Weiss R; Mitrou P; Arasteh K; Schuermann D; Hentrich M; Duehrsen U; Sudeck H; Schmidt-Wolf IG; Anagnostopoulos I; Huhn D;
- Institution
- Private Practice for Hematology, Oncology and Infectious Diseases, Bremen, Germany.
- Journal
- Cancer. 2006 Apr 1;106(7):1560-8.
- Abstract URL
- Click here to view abstract
8. Mitoxantrone, carboplatin, cytosine arabinoside, and methylprednisolone followed by autologous peripheral blood stem cell transplantation: a salvage regimen for patients with refractory or recurrent non-Hodgkin lymphoma.
- Author
- Sora F; Piccirillo N; Chiusolo P; Laurenti L; Marra R; Bartolozzi F; Leone G; Sica S; Sora F; Piccirillo N; Chiusolo P; Laurenti L; Marra R; Bartolozzi F; Leone G; Sica S;
- Institution
- Istituto di Ematologia, Universita Cattolica del Sacro Cuore di Roma, Italy. emacat@rm.unicatt.it
- Journal
- Cancer. 2006 Feb 15;106(4):859-66.
- Abstract URL
- Click here to view abstract
9. A double-blind low dose-finding phase II study of granulocyte colony-stimulating factor combined with chemotherapy for stem cell mobilization in patients with non-Hodgkin's lymphoma.
- Author
- Lefrere F; Zohar S; Bresson JL; Chevret S; Mogenet A; Audat F; Durand-Zaleski I; Ghez D; Dal Cortivo L; Piesvaux P; Cavazzana-Calvo M; Varet B;
- Institution
- Service d'Hematologie Adultes, Centre d'Investigation Clinique Hopital Necker, Direction de la Recherche Clinique, AP-HP, Paris, France. francois.lefrere@nck.aphp.fr
- Journal
- Haematologica. 2006 Apr;91(4):550-3.
- Abstract URL
- Click here to view abstract
10. Feasibility and efficacy of high-dose melphalan, cyclophosphamide, etoposide, and dexamethasone (LEED) chemotherapy with or without rituximab followed by autologous stem cell transplantation for aggressive and relapsed non-Hodgkin's lymphoma.
- Author
- Han LN; Zhou J; Hirose T; Imai Y; Ishiguro T; Chou T;
- Institution
- The First Clinical College of Harbin Medical University, Harbin, China.
- Journal
- Int J Hematol. 2006 Aug;84(2):174-81.
- Abstract URL
- Click here to view abstract
Next: Radiation Therapy
